The bradykinin (BK) B 2 and B 1 receptors (B 2 R, B 1 R) belong to the rhodopsin-like G protein-coupled receptors (GPCRs) and are involved in (patho)physiological processes such as blood pressure regulation or inflammation. They mediate the effects of the pro-inflammatory peptides bradykinin/kallidin and desArg 9 -BK/desArg 10 -kallidin, respectively. Whereas the B 2 R is constitutively expressed and gets internalized upon activation, the B 1 R is especially induced by inflammatory mediators and responds to stimulation with increased surface receptor numbers. Stimulation of both receptors activates phospholipase Cb (PLCb) and mitogen activated protein kinase (MAPK) signaling. Because inflammatory processes are characterized by heat (fever), we analyzed the effect of increased temperature (418C vs. 378C) on B 1 R and B 2 R signaling in HEK 293 and IMR 90 cells. Our results show that signaling of both receptors is temperature-sensitive, however to a different extent and with regard to the investigated pathways. Comparing PLCb activity and Ca 2q -regulated signals, a temperature-dependent increase was only observed for B 1 R but not for B 2 R activation, whereas MAPK activities were doubled at 418C for both receptors. Taken together, our findings suggest that the observed temperature sensitivity of B 1 R-induced PLCb activation is B 1 R-specific. In contrast, the enhanced stimulation of MAPK activity under hyperthermic conditions appears to be a common phenomenon for GPCRs.
Introduction
The bradykinin (BK) B 1 and B 2 receptors (B 1 R and B 2 R) belong to the family A (rhodopsin/b 2 -adrenergic like) of G protein-coupled receptors (GPCRs) and mediate the effects of the pro-inflammatory peptides desArg 9 -BK/desArg 10 -kallidin (DABK/DAK) and BK/kallidin (Lys-BK), respectively. The latter two are often released at sites of inflammation from high-and low-molecular-weight kininogens through the action of kallikreins (Bhoola et al., 1992; Leeb-Lundberg et al., 2005) and can be converted into their desArg-derivatives by carboxypeptidases. Both receptors are involved in numerous (patho)physiological processes including blood pressure regulation, edema formation, pain sensation, inflammation, regulation of cell growth, differentiation, and mobility (Blaukat et al., 2000; Fredriksson et al., 2003; Rosenbaum et al., 2009) . They have been reported to play a role in various diseases such as septic shock, atherosclerosis, and diabetes (Leeb-Lundberg et al., 2005) . Although B 1 R and B 2 R couple to the same G proteins, G q/11 and G i , they differ considerably with regard to their regulation and the dynamics of their subcellular localization. B 2 R is constitutively expressed in many cell types mediating the majority of physiological kinin effects under normal conditions. It gets rapidly internalized and desensitized after activation. In contrast, B 1 R is expressed only weakly in healthy surroundings but is potently induced by pro-inflammatory cytokines in pathological situations such as sepsis or minor inflammation. Moreover, unlike B 2 R, B 1 R does not become desensitized and responds in some cell types to activation with an increase in surface receptor number rather than internalization, e.g., in IMR 90 cells (Phagoo et al., 2000; Leeb-Lundberg et al., 2005) . As both kinin receptors participate in inflammatory processes by mediating the release of proinflammatory cytokines and recruitment of immune cells (McLean et al., 2000; Leeb-Lundberg et al., 2005; Ehrenfeld et al., 2006) , the properties of the B 1 R indicate sustained signaling and thus a role in the prolonged phase of the immune response with amplification of inflammatory processes (Blaukat et al., 1996; Austin et al., 1997; Marceau et al., 1998; Faussner et al., 1999; Phagoo et al., 2000; Marceau et al., 2002; Leeb-Lundberg et al., 2005) . Inflammation is characterized by five cardinal symptoms: pain, redness, swelling, loss of function, and heat (Elliott et al., 1960) . Infection or massive inflammation are often associated with fever and the pro-inflammatory stimuli we.g., lipopolysaccharide, x that promote B 1 R expression are also effective inducers of the febrile response causing a strong increase of body temperature up to 428C (Jansky et al., 1995; Roth and De Souza, 2001) . So far, however, very little information is available on how fever affects the receptors and their signaling. Consequently, in the present study we analyzed the effect of elevated temperature (378C vs. 418C) on various signaling activities of the kinin receptors.
Our findings illustrate for the first time that both B 1 R and B 2 R are temperature-sensitive, however to a different degree with regard to distinct signal pathways. Specifically, B 1 R downstream signal transduction is significantly enhanced under hyperthermic conditions (418C), supporting the notion that B 2 R activation governs the physiological kinin effects, whereas the B 1 R prolongs and amplifies these effects under pathological conditions (Dray, 1997) .
Results
Heat development is one of the five cardinal signs of inflammation, which often is associated with an increase in body temperature (fever). To investigate the effects of fever on receptor signaling, we chose the kinin receptors (B 1 R, B 2 R), as their endogenous agonists bradykinin (BK) and desArg 10 -kallidin (DAK) are pro-inflammatory peptides. In detail, we studied the short-and long-term effects of an increase in temperature from 378C to 418C on selected signaling pathways (PLCb, NFAT, MAPK, AP-1).
Increase of B 1 R-but not of B 2 R-stimulated PLCb activity at 418C
Stimulation of B 1 R as well as of B 2 R results in activation of phospholipase Cb (PLCb), which hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP 2 ) to diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP 3 ), thereby activating protein kinase C (PKC) and increasing intracellular calcium wCa x concentrations. To analyze PLCb activity, total IP accumulation was measured upon receptor activation with 1 mM of the respective agonist, in stably transfected HEK 293 cells at either 378C or 418C. Stimulation of B 1 R with DAK at 378C resulted in an eight-fold increase of IP accumulation and turned almost 14-fold when the stimulation was performed at 418C ( Figure 1A ). In contrast, activation of B 2 R with BK caused a four-fold increase over basal in PLCb activity at 378C, which was not further elevated by raising the temperature to 418C ( Figure 1A ). Basal B 1 R-mediated PLCb activation displayed a non-significant tendency to be increased by the enhanced temperature. We also determined the EC 50 values for total IP accumulation after B 1 R stimulation at 378C and 418C, but in two experiments no difference was observed (0.8/0.9 nM at 378C vs. 0.6/1.5 nM at 418C).
Expressing the B 1 R under the control of the strong cytomegalovirus (CMV) promoter and the B 2 R under the control of the weaker promoter P min led to comparable protein levels of the B 1 R and the B 2 R (1200-2000 fmol/mg protein) in our HEK 293 cells, as determined by radioligand binding assays (Faussner et al., 2009 ) and therefore similar signaling activity. However, to exclude that our observations resulted solely from this heterologous B 1 and B 2 receptor overexpression, we reproduced our findings in the human embryonic lung fibroblast cell line IMR 90, which endogenously expresses the B 2 R (300-800 fmol/mg protein). To perform our experiments in these primary cells, the normally low B 1 R levels (20-50 fmol/mg protein) were induced (100-400 fmol/mg protein) by pre-treatment with IL-1b (2.5 ng/ml) for 4 h, which should reflect a physiologic situation as IL-1b is an endogenous pyrogen involved in the febrile response (Jansky et al., 1995; Roth and De Souza, 2001) . PLCb activation via the B 1 R was significantly increased in DAK-stimulated IMR 90 cells at 418C as compared to the level at 378C ( Figure  1B ), whereas B 2 R-mediated PLCb activity remained at the same level as at 378C (data not shown). Thus, the response of both receptors in the IMR 90 cells reflects their temperature dependency found in the HEK 293 cells, demonstrating that it is not artifact caused by heterologous receptor overexpression.
We further established that high temperature treatment has no significant influence on cell surface receptor density by radioligand binding assays following incubation at 378C and 418C in both cell lines (data not shown).
Next we investigated whether the stronger signaling at 418C vs. 378C could also be observed further downstream in the IP signaling cascade. binds to calmodulin, which consequently activates the phosphatase calcineurin. Calcineurin in turn dephosphorylates the nuclear factor of activated T-cells (NFAT) transcription factor, allowing it to translocate into the nucleus and regulate gene expression by binding to its responsive elements (Muller and Rao, 2010) . In our specific HEK 293 reporter cell line, the nuclear NFAT transcription factor promotes the expression of the reporter gene Gaussia luciferase. The NFAT reporter host cell line transiently expressing B 1 R or B 2 R was stimulated with DAK or BK (1 mM each), respectively, and Gaussia luciferase activity was determined 24 h later. NFAT-mediated luciferase action following B 1 R stimulation with DAK at 418C was increased two-fold as compared to the effects of a stimulation performed at 378C. In contrast, NFAT-mediated Gaussia luciferase activity induced by B 2 R stimulation with BK remained the same at 418C as at 378C (Figure 2). These findings are consistent with the already described observations concerning the short-term stimulation of PLCb activity ( Figure 1 ) and confirm that the higher temperature (418C) increases only B 1 R-but not B 2 Ractivated Ca 2q -dependent signals.
Requirement of G q/11 and G i for ERK1/2 activation via B 1 R and B 2 R
Both kinin receptors activate the MAPK signaling cascade, which is involved in major cellular processes such as cell growth, development, differentiation, and proliferation (Dhanasekaran et al., 1998; Dhillon et al., 2007; Zhang and Dong, 2007) . Consequently, we analyzed the influence of increased temperature on the PKC-mediated extracellular signal-regulated kinase 1/2 (ERK1/2) pathway of the MAPK signaling cascades. It has been reported that efficient B 2 Rmediated MAPK activation requires coupling to both G q/11 and G i (Blaukat et al., 2000) . As little was known, however, about the requirements of B 1 R-mediated MAPK stimulation, we first addressed the question of whether the B 1 R also belongs to the group of dually coupled receptors (to G q/11 and G i protein subtypes) with regard to MAPK signal transmission, before analyzing the existence of a temperature dependence of B 1 R-and B 2 R-mediated signaling. In order to determine the contribution of G q/11 , HEK 293 cells stably expressing the B 1 R or the B 2 R were treated for 30 min with 5 mM BIM (bisindolylmaleimide), a potent PKC inhibitor, or for 16 h with 75 ng/ml Ptx (pertussis toxin) to inactivate G i . Thereafter, ERK1/2 phosphorylation was determined upon stimulation of B 1 R and B 2 R with 1 mM of the respective receptor ligand for 5 min. Treatment with 1 mM PMA (phorbol-12-myristate-13-acetate), a strong PKC activator, for 10 min served as positive control and reference for maximal response. The DAK-and BK-induced increases in ERK1/2 phosphorylation were cut by approximately half upon pretreatment with BIM or Ptx, revealing a contribution of G q/11 for efficient signal transduction, as well as the necessity of G i -coupling ( Figure 3A , B). The combined treatment with the PKC-and G i -inhibiting agents had an additive effect on ERK1/2 phosphorylation for both kinin receptors, leading to an almost complete inhibition of ERK1/2 activation ( Figure  3A , B). These results demonstrate that the B 1 R also belongs to the group of receptors that are dually coupled to efficiently activate MAPK signaling.
Increase of B 1 R-and B 2 R-mediated ERK1/2 phosphorylation at 418C
To determine the ERK1/2 activation potential in an inflammatory environment with increased temperatures, we firstly stimulated B 1 R-or B 2 R-expressing HEK 293 cells with 100 nM of the appropriate receptor agonist at 378C and at 418C for different time periods. Again, stimulation with PMA (1 mM) served as positive control and reference of maximal response. ERK1/2 phosphorylation was increased at 418C as compared to the activity level at 378C following stimulation of B 1 R as well as of B 2 R ( Figure 4A , B). The differences in ERK1/2 activation between 378C and 418C were most prominent after 5 and 10 min of stimulation of both receptors. Stimulation of B 1 R with DAK for 5 and 10 min resulted in a 26-31% increase of ERK1/2 phosphorylation at 418C compared to 378C. Triggering the B 2 R also led to a significant signal elevation (18-21%) at 418C as compared to 378C after 5 and 10 min. A clear increase of ERK1/2 activation after stimulation of B 1 R or B 2 R was also found in IMR 90 cells at 418C as compared to 378C ( Figure  4C ), proving the potential physiological relevance of augmented receptor-mediated MAPK signaling activity at higher temperatures that occur during fever in inflammatory proc- completely inhibited ERK1/2 phosphorylation, verifying signal transmission via the above-mentioned receptors ( Figure  4A ). Unlike the results observed for PLCb-mediated and Ca 2q -regulated signal transduction, these findings show that with regard to ERK1/2 pathway activation, signaling activity of both kinin receptors increases with the temperature rise. This temperature sensitivity, however, is apparently a property of the ERK1/2 pathway itself, as it was basically also observed with the direct stimulation using PMA, however not reaching statistical significance (increases of 25"12% and 21"16% (ns4) of phospho-ERK1/2 levels at 418C as compared to 378C following PMA treatment of B 1 R or B 2 Rexpressing cells, respectively; Figure 4A ).
Elevation of AP-1-mediated reporter activity via B 1 R and B 2 R at 418C
The ERK1/2/MAPK pathway was reported to possibly participate in the regulation of activator protein 1 (AP-1), a transcription factor comprised of JUN homo-or FOS-JUN heterodimers (Yordy and Muise-Helmericks, 2000; Pruitt and Der, 2001) . AP-1 expression results in the regulation of key cell cycle regulators such as D-type cyclins, enabling the cell to progress through the G1 phase of the cell cycle (Yordy and Muise-Helmericks, 2000; Pruitt and Der, 2001) . In order to detect temperature-sensitive long-term effects of B 1 R and B 2 R signaling in the context of ERK1/2 signal transduction, we investigated the temperature dependence of B 1 R and B 2 R concerning their ability to activate AP-1-promoted Gaussia luciferase gene expression.
An AP-1 reporter cell line transiently expressing the B 1 R or B 2 R was stimulated for 10 min at 378C or 418C with 1 mM of DAK or BK, respectively. After 24 h of further incubation at the same temperature, Gaussia luciferase activity was monitored. A four-to five-fold increase in enzyme activity was observed at 418C as compared to 378C following stimulation of both receptors ( Figure 5 ). These findings are in agreement with our observations regarding B 1 R-or B 2 Rdependent ERK1/2 phosphorylation (Figure 4) , rendering a participation of the ERK1/2 pathway in AP-1 transcription factor regulation feasible.
Discussion
Although pathological situations such as severe inflammation are often associated with fever, little is known on how a temperature increase modifies stimulation and the following signaling of cellular membrane receptors. Such information could help to decide whether to fight against fever or to accept the temperature rise as therapeutically useful. As kinin receptors are the mediators of the effects of the proinflammatory kinin peptide hormones under inflammatory pathological conditions (e.g., sepsis) (Marceau et al., 2002; Leeb-Lundberg et al., 2005) , these receptors appeared to be ideal to perform investigations on the temperature sensitivity of membrane receptors.
In our study, we looked at four different signaling pathways (depicted in Figure 6 ), comprising short-term effects of receptor activation (PI hydrolysis and ERK1/2 activation) as well as long-term effects (NFAT-and AP-1-reporter activity). Our results show that one has to differentiate between the influences of an increase in temperature on the signaling pathways themselves and effects that are specific for a receptor activating these pathways. ERK1/2 phosphorylation and AP-1-regulated reporter gene activation were significantly enhanced at 418C as compared to 378C upon stimulation of both kinin receptors. This temperature dependency was basically also observed when the ERK1/2 pathway was stimulated with the phorbolester PMA, however not reaching statistical significance wwith increases of 21-24% in ERK1/2 phosphorylation at 418C as compared to 378C (see Figure 4 ) and 1.7"0.3-fold enhanced AP-1 reporter activity at 418C over 378C (see Figure 5) x, i.e., without the initial receptor and G protein activation step. The augmented ERK1/2 activation at 418C may, therefore, not be specific for the kinin receptors, but can also most likely be After further incubation in DMEM with 0.5% FCS for 24 h at 378C or 418C, respectively, luciferase activity was measured as described under 'Material and methods' and normalized to stimulated luciferase activity at 378C, which was 6"2-fold over basal activity following B 1 R stimulation and 3"1-fold after B 2 R activation. detected for other GPCRs activating this pathway. The effect of a temperature rise on ERK1/2 activation was also apparently not dependent on the cell type as it was assessed for the kinin receptors heterologously expressed in HEK 293 cells and for those expressed endogenously in IMR 90 fibroblasts as well (see Figure 4C) .
In contrast, a temperature sensitivity of PI hydrolysis or the NFAT-regulated reporter activity was found only after stimulation of the B 1 R, but not of the B 2 R (see Figure 1 and Figure 2 ). This indicates that the responses of these two pathways are not generally enhanced with temperature, but solely when activated via specific receptors such as the B 1 R. As shown in different cell types (HEK 293, IMR 90 fibroblasts), the temperature sensitivity is not a common property of the pathway, but rather an intrinsic quality of the respective receptor, in our case of the B 1 R.
Although both kinin receptors apparently couple to the same signaling pathways, thereby activating identical second messengers and kinase cascades, they otherwise exhibit quite contrasting regulatory patterns. The B 2 R gets rapidly phosphorylated, desensitized, and internalized upon stimulation with an agonist. In contrast, the B 1 R does not become phosphorylated and does not undergo agonistinduced desensitization (Leeb-Lundberg et al., 2005) . Consequently, while the B 2 R induces a transient increase in PI hydrolysis and is only weakly dependent on extracellular Ca 2q , the B 1 R promotes sustained signaling and is significantly dependent on extracellular Ca 2q (Tropea et al., 1993; Leeb-Lundberg et al., 2005) . Moreover, in contrast to the B 2 R, which is constitutively expressed in many cells, the B 1 R is induced preferentially under pathological conditions by inflammatory cytokines (Leeb-Lundberg et al., 2005) . All these differences led to the assumption that the B 2 R acts during the acute phase of an inflammation or other pathological situations, whereas the B 1 R takes over as (patho)physiologically dominating kinin receptor in the chronic phase after being expressed in sufficient amounts (Enquist et al., 2007) . The observed different temperature sensitivity of both receptors in our experiments further strengthens this notion of a switch from B 2 R to enhanced B 1 R signal transduction in an inflammatory situation with elevated temperatures. Future studies will have to determine how the specifically increased B 1 R signaling is achieved, whether through enhanced efficacy as a guanine-nucleotide exchange factor for G proteins or via other temperaturesensitive factors (e.g., Ca 2q channels translocated to the plasma membrane), which may exert their augmenting effect sufficiently only with receptors that do not become immediately desensitized, such as the B 1 R.
Furthermore, several studies have demonstrated that kinin receptors are involved in leukocyte migration, and are upregulated on neutrophils in a variety of inflammatory disorders, e.g., asthma and rheumatoid arthritis (Bertram et al., 2007) . The temperature sensitivity of the kinin receptors, as observed by us, is therefore most likely of therapeutic relevance. In this context, it is of interest that Gouveia et al.
recently reported that the application of the drug lovastatin to rats with pilocarpine-induced status epilepticus resulted in a reduction of body temperature, in decreased IL-1b and IL-6 levels, and importantly in a decline of B 1 R expression. The authors concluded that normalization of body temperature could be an approach of neuroprotection in generalized convulsive forms of status epilepticus (Gouveia et al., 2011) . Assuming that B 1 R signaling is increased during status epilepticus due to higher temperatures, neuroprotection might occur partly because of a diminution of B 1 R activity at normal physiological temperatures.
Interestingly, it is worth mentioning that GPCRs cannot only be affected in their signaling properties by the surrounding temperature as shown herein, but may even act as a temperature sensor as has recently been reported for the GPCR rhodopsin in Drosophila larvae (Shen et al., 2011) .
Taken together, our findings illustrate, to the best of our knowledge for the first time, that some GPCR signaling pathways (e.g., ERK1/2, AP-1) are significantly affected by the (patho)physiologically relevant temperature increase from 378C to 418C and thus most likely will respond to all activating GPCRs with a stronger signal at the higher temperature. In contrast, other pathways (e.g., PI hydrolysis, NFAT) are basically insensitive to (patho)physiological temperature alterations. An observed effect of temperature on a response in these cases is therefore specific for the activating receptor, as demonstrated for the B 1 R in our experiments. Since the signaling activity of the B 1 R is specifically increased in hyperthermic surroundings in addition to its upregulation under fever-associated inflammatory conditions, targeting this GPCR might be of special therapeutic relevance for the decision of whether or not to counteract fever.
Materials and methods

Materials
Flp-In TREx-293 (HEK 293) cells were bought from Invitrogen (Karlsruhe, Germany) and IMR 90 cells from ATCC (Manassas, USA). w2,3-prolyl-3,4-3 Hxbradykinin (80 Ci/mmol) and myo-w2-3 Hxinositol (22 Ci/mmol) were purchased from Perkin Elmer Life Sciences (Boston, USA), w3, 3 Hx (70 Ci/mmol) from Hartmann Analytic (Braunschweig, Germany). Bradykinin and desArg 10 -Kallidin were synthesized by Bachem (Heidelberg, Germany). Fugene was from Roche (Mannheim, Germany), EcoTransfect from Oz Biosciences (Marseille, France). Poly-D-Lysine, captopril, 1.10-phenanthroline, bacitracin and pertussis toxin were obtained from Sigma-Aldrich (Taufkirchen, Germany). Cell culture media and additions were from PAA Laboratories (Coelbe, Germany), Opti-MEM I from Gibco (Darmstadt, Germany). Bisindolylmaleimide I, phorbol-12-myristate-13-acetate and ionomycin were purchased from Calbiochem (Darmstadt, Germany). Monoclonal phospho-ERK1/2-and ERK1/2-antibodies, as well as the peroxidase-labeled horse anti-mouse IgG-antibody were supplied by Cell Signaling Technology (Massachusetts, USA).
Gene expression and cell culture
The sequence of the B 1 R, codon-optimized for expression in human cells and synthesized by GeneArt (Regensburg, Germany) and the sequence of the B 2 R starting with the third encoded Met (Hess et al., 1992) , were cloned into the HindIII and XhoI sites of the pcDNA5/FRT/TO vector (Invitrogen). A hemagglutinin-tag (MGY-PYDVPDYAGS) preceded the receptor sequences. For stable expression, the Flp-In system with the host cell line and recombinase-directed insertion of the plasmid harboring the gene of interest was applied. The HEK 293 cells cultivated in Dulbecco's modified Eagle's Medium (DMEM) with 10% FCS and penicillin (100 U/ml)/streptomycin (100 mg/ml) were transfected using the transfection reagent Fugene according to the manufacturer's instructions. Selection of stable clones was achieved using hygromycin B (250 mg/ml). IMR 90 cells were cultured in minimum essential medium Eagle (MEM) with Earle's Salts (10% FCS, 1% glutamine). To generate reporter gene host cell lines, HEK 293 cells were stably transfected with a pcDNA3.1/G418 vector (Invitrogen), which had the CMV promoter replaced by the respective transcriptional response elements inserted in multiple copies (4=GGAGGAAAAACTGTTTCATACAGAAAGGCGT for NFAT, 6=AGCCTGACGTCAGAG for AP-1) followed by the Gaussia luciferase gene cloned into the EcoRI and XhoI sites of the vector (Larissa Ring et al., unpublished results). Cells were selected in the presence of G418 (1 mg/ml).
Radioligand binding assays
Monolayers of IMR 90 cells or stably transfected HEK 293 cells in 24-wells were rinsed twice with ice-cold PBS and incubated on ice with the respective radiolabeled agonist in incubation buffer (40 mM PIPES, 109 mM NaCl, 5 mM KCl, 0.1% glucose, 0.05% BSA, 2 mM CaCl 2 , 1 mM MgCl 2 , pH 7.4, degradation inhibitors for B 1 R: 0.5 mM bacitracin, 0.02 mM 1.10-phenanthroline, 100 mM captopril; degradation inhibitors for B 2 R: 2 mM bacitracin, 0.8 mM 1.10-phenanthroline, 100 mM captopril) for 90 min. After washing with ice-cold PBS, surface-bound w 3 Hx-labeled ligand was dissociated by incubation (10 min, 48C) with 200 ml of ice-cold 0.5 M NaCl/0.2 M acetic acid solution, pH 2.7, and counted in a b-counter after transfer to a scintillation vial and addition of scintillation liquid. Nonspecific binding was determined in the presence of a 1000-fold excess of non-radiolabeled ligand.
Determination of total inositol phosphate (IP) release
IMR 90 cells or stably transfected HEK 293 cells, plated on 12-or 24-wells, respectively, were labeled overnight with 1 mCi w 3 Hxinositol/ml in 500/250 ml of Opti-MEM I. Cells were rinsed twice with ice-cold PBS and pre-incubated for 90 min on ice in incubation buffer supplemented with 50 mM LiCl with or without 1 mM of the indicated ligand. To determine EC 50 values, cells were pre-incubated with increasing concentrations (10 -12 -10 -6 M) of ligand solution at 48C. Cells were then stimulated for 30 min at either 378C or 418C. Stimulation was terminated by exchange of ligand solution for 1.5/0.75 ml of ice-cold 20 mM formic acid solution. After 60 min, the amount of total IP in the formic acid extract was determined by column chromatography using AG 1-X8 columns (Bio-Rad, Munich, Germany) as described earlier (Faussner et al., 2009 ).
Determination of ERK1/2 phosphorylation
Confluent IMR 90 cells or HEK 293 cells on 6-well plates expressing the respective kinin receptor were serum-starved by incubation in Opti-MEM I. After 24 h they were stimulated with 1 mM of PMA, the given concentrations of DAK or BK for the indicated times at the indicated temperature with or without pre-incubation with 1 mM Lys-des-Arg 9 -wLeu 8 x-BK, 1 mM Icatibant, 5 mM BIM for 30 min, or pertussis toxin (75 ng/ml) for 16 h. Subsequently, the monolayers were washed with ice-cold PBS, scraped in lysis buffer (10 mM Tris-HCl, pH 7,4, 150 mM NaCl, 25 mM KCl, 0.1% Triton X-100) supplemented with a protease inhibitor cocktail (complete Mini, EDTA-free; Roche, Mannheim, Germany) and centrifuged at 14 000 rpm for 15 min at 48C. Cell lysates were mixed with NuPAGE LDS Sample Buffer (Invitrogen) supplemented with DTT (0.1 M) and heated at 998C for 10 min. Equal amounts of protein were separated by 4-12% SDS-PAGE and transferred to a 0.45-mm nitrocellulose membrane (Bio-Rad). After 60 min in blocking buffer w5% milk powder in Tris-buffered saline with 0.1% Tween 20 (TBST)x the primary antibodies (phospho-ERK1/2, ERK1/2, monoclonal, Cell Signaling) were added for 60 min in blocking buffer. After washing with TBST the secondary peroxidase-labeled horse anti-mouse IgG (Cell Signaling) was added for 60 min in blocking buffer, followed by thorough washing and visualization of the immuno-labeled proteins using Western blot Chemiluminescence Reagent Plus (Roche) on X-ray hyperchemiluminescence films (Hyperfilm ECL, GE Healthcare). Band densities were quantified using the according software, ImageJ (Abramoff et al., 2004; Rasband, 1997 Rasband, -2011 . Protein levels were normalized to the corresponding PMA-stimulated phospho-ERK1/2 levels at 378C as maximum responses.
Reporter gene assays
Reporter host cell lines on 24-wells were transiently transfected with B 1 R or B 2 R using the transfection reagent EcoTransfect (0.2 mg DNA/0.6 ml EcoTransfect per well) and incubated overnight in complete cell culture medium. The next day, cells were induced with tetracyclin (0.5 mg/ml) in medium with reduced FCS (0.5%). 24 h later, cells were stimulated for 10 min at 378C or 418C with 1 mM of the respective ligand (DAK/BK) and further incubated at 378C or 418C overnight. 1 mM PMA"1 mM ionomycin served as positive controls as indicated. 24 h post stimulation, 75 ml of the cell culture supernatant, containing secreted Gaussia luciferase, was transferred to a 96-well plate. Upon addition of 25 ml of Gaussia luciferase substrate (5.72 mM Coelenterazin, 2.2 mM Na 2 EDTA, 0.22 M K x PO 4 , pH 5.1; 0.44 mg/ml BSA, 1.1 M NaCl, 1.3 mM NaN 2 , pH 5.0), its activity was monitored within 1 min in a Transluminator DarkReader (Tecan safire2, Clare Chemical Research, Dolores, USA), followed by quantification using XFluor4 Safire2 according software (Tecan, Crailsheim, Germany) .
Protein quantification
Total protein quantification was performed using the Micro BCA Protein assay reagent kit from Pierce (Rockford, IL, USA) with BSA as standard.
Data analysis
All data analysis was performed with GraphPad Prism for Macintosh, Version 4.0c (GraphPad Software, Inc., San Diego, CA, USA). Data were assessed by appropriate analysis of variance (ANOVA or Student's t-test), with post hoc analysis as indicated (Bonferroni or Dunnett).
